Gross J B, Caldwell C B, Shaw L M, Apfelbaum J L
Anesthesiology. 1984 Dec;61(6):662-5. doi: 10.1097/00000542-198412000-00006.
The authors studied the effect of lidocaine infusion on the ventilatory response to isocapnic hypoxia in nine healthy male subjects. Lidocaine infusion (serum concentration 3.6 +/- 0.1 micrograms/ml) was associated with a decrease in the shape factor, "A," of the hypoxic ventilatory response in eight of our nine subjects (P less than 0.02). Overall, "A" decreased from 419 +/- 102 1 . min-1 . mmHg before lidocaine to 335 +/- 77 1 . min-1 . mmHg during lidocaine infusion (mean +/- SEM, N = 9). The authors conclude that despite significant intersubject variability, clinically useful serum lidocaine concentrations depress hypoxic ventilatory drive. Patients with carbon dioxide retention, whose resting ventilation depends on hypoxic drive, may be at risk of ventilatory failure when lidocaine is administered for arrhythmia control or regional anesthesia.
作者研究了利多卡因输注对9名健康男性受试者等碳酸血症性低氧通气反应的影响。在我们的9名受试者中,有8名受试者利多卡因输注(血清浓度3.6±0.1微克/毫升)与低氧通气反应的形状因子“A”降低相关(P<0.02)。总体而言,“A”从利多卡因输注前的419±102升·分钟⁻¹·毫米汞柱降至利多卡因输注期间的335±77升·分钟⁻¹·毫米汞柱(平均值±标准误,N = 9)。作者得出结论,尽管个体间存在显著差异,但临床上有效的血清利多卡因浓度会抑制低氧通气驱动。对于静息通气依赖低氧驱动的二氧化碳潴留患者,在使用利多卡因控制心律失常或进行区域麻醉时,可能有发生通气衰竭的风险。